We are a focused preclinical discovery organization working in partnership with other companies to determine preclinical proof of concept and drive novel therapies into the clinic. We look forward to working with you in the future.
News
- 01/05/09
VivoPath expands pharmacology team and opens for business
VivoPath signs lease deal on built out laboratory space
- 10/26/08
Senior drug discovery professionals from Sirtris start up VivoPath
VivoPath expands pharmacology team and opens for business
WORCESTER, MA – January, 5th, 2009 – VivoPath LLC, a pre-clinical proof of concept contract research organization, announced the opening of its laboratories and an addition to their leadership team.Peggy Sposato joins VivoPath as Group Leader, Pharmacology and will be responsible for managing the in vivo research team. Peggy brings both significant technical expertise and start up skills to VivoPath. She spent six years at ViaCell helping to build the company from the early days as t. breeders. She brings expertise in metabolic disease, oncology and regenerative medicine to the team.“VivoPath is delighted to welcome Peggy who brings to our team a wealth of experience in discovery research, particularly in pharmacokinetics and efficacy models.” said Phil Lambert, Ph.D., CSO of VivoPath. “We are excited to begin operations and offer an important service to the biotech and pharmaceutical community"
